Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have earned an average rating of “Moderate Buy” from the five ratings firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is GBX 2,298.33.
JMAT has been the subject of a number of analyst reports. UBS Group reiterated a “neutral” rating and set a GBX 2,200 price target on shares of Johnson Matthey in a research note on Friday, May 22nd. Jefferies Financial Group reissued a “restricted” rating on shares of Johnson Matthey in a research report on Friday, May 29th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Johnson Matthey from GBX 2,120 to GBX 2,400 and gave the stock a “buy” rating in a research report on Friday, May 29th. Finally, Berenberg Bank lifted their target price on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a “buy” rating in a research report on Monday, June 1st.
Check Out Our Latest Stock Analysis on JMAT
Insider Activity
Johnson Matthey Price Performance
JMAT stock opened at GBX 2,114 on Tuesday. The company has a market capitalization of £3.54 billion, a P/E ratio of -36.96, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.93. The company has a debt-to-equity ratio of 69.69, a quick ratio of 0.76 and a current ratio of 1.56. Johnson Matthey has a 52-week low of GBX 1,674 and a 52-week high of GBX 2,434. The business has a 50-day simple moving average of GBX 2,082.82 and a two-hundred day simple moving average of GBX 2,109.85.
Johnson Matthey (LON:JMAT – Get Free Report) last released its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share (EPS) for the quarter. The business had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%. Research analysts expect that Johnson Matthey will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Read More
- Five stocks we like better than Johnson Matthey
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
